ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA)

Historical Holders from Q1 2019 to Q3 2025

Symbol
ZVRA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
56,066,823
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
39,871,097
Holdings value
$379,159,393
% of all portfolios
0.002%
Number of holders
161
Number of buys
104
Number of sells
-47
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.6% $29,501,437 4,080,420 BlackRock, Inc. 31 Dec 2024
Woodline Partners LP 6.2% $33,058,120 3,476,143 Woodline Partners LP 30 Sep 2025
Nantahala Capital Management, LLC 4.38% -19.7% $16,920,608 -$4,220,064 2,340,333 -20% Nantahala Capital Management, LLC 31 Dec 2024
Adage Capital Management, L.P. 3.96% -41.1% $21,159,750 -$13,551,750 2,225,000 -39% Adage Capital Management, L.P. 30 Sep 2025

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 39,871,097 $379,159,393 +$36,766,973 $9.51 161
2025 Q2 36,165,830 $318,624,169 +$9,847,978 $8.81 119
2025 Q1 35,351,805 $264,779,873 +$11,437,756 $7.49 109
2024 Q4 33,925,967 $282,929,757 +$43,767,647 $8.34 108
2024 Q3 28,925,387 $200,746,422 +$88,219,086 $6.94 105
2024 Q2 16,043,055 $78,561,424 +$9,453,621 $4.9 92
2024 Q1 13,910,496 $80,679,510 +$7,031,758 $5.8 88
2023 Q4 12,678,435 $83,043,757 +$12,292,891 $6.55 83
2023 Q3 10,800,557 $52,059,801 +$12,731,917 $4.82 76
2023 Q2 8,153,478 $41,582,121 +$9,633,583 $5.1 69
2023 Q1 6,153,233 $33,836,990 +$3,326,482 $5.5 59
2022 Q4 5,912,306 $27,146,724 -$3,423,716 $4.59 66
2022 Q3 6,683,041 $41,695,480 -$3,025,737 $6.24 63
2022 Q2 7,231,996 $32,280,920 -$8,047,771 $4.46 61
2022 Q1 8,999,997 $45,269,137 +$8,091,446 $5.03 72
2021 Q4 7,241,315 $62,973,380 -$7,065,660 $8.71 72
2021 Q3 7,785,907 $72,596,741 -$2,908,464 $9.33 65
2021 Q2 7,669,356 $98,321,566 +$70,526,213 $12.82 66
2021 Q1 2,343,772 $21,986,514 +$21,240,741 $9.2 46
2020 Q4 1,660 $19,000 +$14,000 $11.7 2
2020 Q3 410 $5,000 $12.2 1
2020 Q2 410 $5,000 $12.2 1
2020 Q1 410 $5,000 $12.2 1
2019 Q4 410 $5,000 $12.2 1
2019 Q3 410 $5,000 $12.2 1
2019 Q2 410 $5,000 $12.2 1
2019 Q1 410 $5,000 $12.2 1